SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Bio Key International Inc. – ‘10-Q’ for 6/30/20 – ‘EX-101.SCH’

On:  Friday, 8/14/20, at 4:51pm ET   ·   For:  6/30/20   ·   Accession #:  1437749-20-18059   ·   File #:  1-13463

Previous ‘10-Q’:  ‘10-Q’ on 6/8/20 for 3/31/20   ·   Next:  ‘10-Q’ on 11/16/20 for 9/30/20   ·   Latest:  ‘10-Q’ on 11/20/23 for 9/30/23   ·   3 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/14/20  Bio Key International Inc.        10-Q        6/30/20   78:6.3M                                   RDG Filings/FA

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    629K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     28K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     28K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     23K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     23K 
12: R1          Document And Entity Information                     HTML     54K 
13: R2          Condensed Consolidated Balance Sheets (Current      HTML    123K 
                Period Unaudited)                                                
14: R3          Condensed Consolidated Balance Sheets (Current      HTML     29K 
                Period Unaudited) (Parentheticals)                               
15: R4          Condensed Consolidated Statements of Operations     HTML     87K 
                (Unaudited)                                                      
16: R5          Condensed Consolidated Statements of Stockholders'  HTML    111K 
                Equity (Deficit) (Unaudited)                                     
17: R6          Condensed Consolidated Statements of Cash Flows     HTML    162K 
                (Unaudited)                                                      
18: R7          Note 1 - Nature of Business and Basis of            HTML     43K 
                Presentation                                                     
19: R8          Note 2 - Going Concern                              HTML     29K 
20: R9          Note 3 - Revenue From Contracts With Customers      HTML    112K 
21: R10         Note 4 - PistolStar Inc. Acquisition                HTML     64K 
22: R11         Note 5 - Accounts Receivable                        HTML     42K 
23: R12         Note 6 - Share Based Compensation                   HTML     38K 
24: R13         Note 7 - Factoring                                  HTML     42K 
25: R14         Note 8 - Inventory                                  HTML     32K 
26: R15         Note 9 - Resalable Software License Rights          HTML     33K 
27: R16         Note 10 - Investment                                HTML     27K 
28: R17         Note 11 - Related Party Transactions                HTML     32K 
29: R18         Note 12 - Convertible Notes Payable                 HTML     98K 
30: R19         Note 13 - Leases                                    HTML     48K 
31: R20         Note 14 - Earnings (Loss) Per Share - Common Stock  HTML     69K 
                ("Eps")                                                          
32: R21         Note 15 - Stockholders' Equity                      HTML     41K 
33: R22         Note 16 - Fair Values of Financial Instruments      HTML     26K 
34: R23         Note 17 - Major Customers and Accounts Receivables  HTML     27K 
35: R24         Note 18 - Payment Protection Program Term Note      HTML     28K 
36: R25         Note 19 - Subsequent Events                         HTML     39K 
37: R26         Significant Accounting Policies (Policies)          HTML     48K 
38: R27         Note 3 - Revenue From Contracts With Customers      HTML     91K 
                (Tables)                                                         
39: R28         Note 4 - PistolStar Inc. Acquisition (Tables)       HTML     59K 
40: R29         Note 5 - Accounts Receivable (Tables)               HTML     38K 
41: R30         Note 6 - Share Based Compensation (Tables)          HTML     37K 
42: R31         Note 7 - Factoring (Tables)                         HTML     58K 
43: R32         Note 8 - Inventory (Tables)                         HTML     31K 
44: R33         Note 12 - Convertible Notes Payable (Tables)        HTML     72K 
45: R34         Note 13 - Leases (Tables)                           HTML     50K 
46: R35         Note 14 - Earnings (Loss) Per Share - Common Stock  HTML     68K 
                ("Eps") (Tables)                                                 
47: R36         Note 2 - Going Concern (Details Textual)            HTML     37K 
48: R37         Note 3 - Revenue From Contracts With Customers      HTML     29K 
                (Details Textual)                                                
49: R38         Note 3 - Revenue From Contracts With Customers -    HTML     52K 
                Disaggregation of Revenue (Details)                              
50: R39         Note 4 - PistolStar Inc. Acquisition (Details       HTML     36K 
                Textual)                                                         
51: R40         Note 4 - PistolStar Inc. Acquisition - Assets       HTML     54K 
                Acquired and Liabilities Assumed (Details)                       
52: R41         Note 4 - PistolStar Inc. Acquisition - Assets       HTML     24K 
                Acquired and Liabilities Assumed (Details)                       
                (Parentheticals)                                                 
53: R42         Note 4 - PistolStar Inc. Acquisition -              HTML     29K 
                Finite-lived Intangible Assets Acquired (Details)                
54: R43         Note 4 - PistolStar Inc. Acquisition - Pro Forma    HTML     30K 
                Information (Details)                                            
55: R44         Note 5 - Accounts Receivable (Details Textual)      HTML     40K 
56: R45         Note 5 - Accounts Receivable - Summary of Accounts  HTML     37K 
                Receivable (Details)                                             
57: R46         Note 6 - Share Based Compensation - Expenses for    HTML     27K 
                Continuing Operations (Details)                                  
58: R47         Note 7 - Factoring (Details Textual)                HTML     31K 
59: R48         Note 7 - Factoring - Due From Factor (Details)      HTML     25K 
60: R49         Note 7 - Factoring - Fees (Details)                 HTML     22K 
61: R50         Note 8 - Inventory - Components of Inventory        HTML     28K 
                (Details)                                                        
62: R51         Note 9 - Resalable Software License Rights          HTML     41K 
                (Details Textual)                                                
63: R52         Note 10 - Investment (Details Textual)              HTML     31K 
64: R53         Note 11 - Related Party Transactions (Details       HTML     68K 
                Textual)                                                         
65: R54         Note 12 - Convertible Notes Payable (Details        HTML    161K 
                Textual)                                                         
66: R55         Note 12 - Convertible Notes Payable - Convertible   HTML     59K 
                Notes Payable (Details)                                          
67: R56         Note 13 - Leases - Operating Lease Balance Sheet    HTML     38K 
                Information (Details)                                            
68: R57         Note 13 - Leases - Supplemental Cash Flow           HTML     22K 
                Information Related to Leases (Details)                          
69: R58         Note 13 - Leases - Operating Lease Liability        HTML     35K 
                Maturity (Details)                                               
70: R59         Note 14 - Earnings (Loss) Per Share - Common Stock  HTML     37K 
                ("EPS") - Reconciliation of Numerator of Basic and               
                Diluted EPS Calculations (Details)                               
71: R60         Note 14 - Earnings (Loss) Per Share - Common Stock  HTML     36K 
                ("EPS") - Securities Excluded From the Diluted Per               
                Share Calculation (Details)                                      
72: R61         Note 15 - Stockholders' Equity (Details Textual)    HTML    109K 
73: R62         Note 17 - Major Customers and Accounts Receivables  HTML     36K 
                (Details Textual)                                                
74: R63         Note 18 - Payment Protection Program Term Note      HTML     23K 
                (Details Textual)                                                
75: R64         Note 19 - Subsequent Events (Details Textual)       HTML     76K 
77: XML         IDEA XML File -- Filing Summary                      XML    144K 
76: EXCEL       IDEA Workbook of Financial Reports                  XLSX     81K 
 6: EX-101.INS  XBRL Instance -- bkyi-20200630                       XML   1.87M 
 8: EX-101.CAL  XBRL Calculations -- bkyi-20200630_cal               XML    125K 
 9: EX-101.DEF  XBRL Definitions -- bkyi-20200630_def                XML   1.29M 
10: EX-101.LAB  XBRL Labels -- bkyi-20200630_lab                     XML   1.03M 
11: EX-101.PRE  XBRL Presentations -- bkyi-20200630_pre              XML   1.31M 
 7: EX-101.SCH  XBRL Schema -- bkyi-20200630                         XSD    214K 
78: ZIP         XBRL Zipped Folder -- 0001437749-20-018059-xbrl      Zip    159K

‘EX-101.SCH’   —   XBRL Schema — bkyi-20200630

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" standalone="no" encoding="windows-1252"?>
<!-- Generated by ThunderDome XBRL - 07:07PM UTC 2020-08-14 -->
<xsd:schema xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:bkyi="http://bio-key.com/20200630" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://bio-key.com/20200630">
<xsd:import namespace="http://xbrl.sec.gov/sic/2020-01-31" schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2020-01-31" schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
<xsd:import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2020-01-31" schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd"/>
<xsd:import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bkyi-20200630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bkyi-20200630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bkyi-20200630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bkyi-20200630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://bio-key.com/20200630/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 000 - Document - Document And Entity Information </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-condensed-consolidated-balance-sheets-current-period-unaudited" roleURI="http://bio-key.com/20200630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals" roleURI="http://bio-key.com/20200630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-condensed-consolidated-statements-of-operations-unaudited" roleURI="http://bio-key.com/20200630/role/statement-condensed-consolidated-statements-of-operations-unaudited">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-condensed-consolidated-statements-of-stockholders-equity-deficit-unaudited" roleURI="http://bio-key.com/20200630/role/statement-condensed-consolidated-statements-of-stockholders-equity-deficit-unaudited">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 004 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-condensed-consolidated-statements-of-cash-flows-unaudited" roleURI="http://bio-key.com/20200630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-1-nature-of-business-and-basis-of-presentation" roleURI="http://bio-key.com/20200630/role/statement-note-1-nature-of-business-and-basis-of-presentation">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 006 - Disclosure - Note 1 - Nature of Business and Basis of Presentation </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-2-going-concern" roleURI="http://bio-key.com/20200630/role/statement-note-2-going-concern">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 007 - Disclosure - Note 2 - Going Concern </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-3-revenue-from-contracts-with-customers" roleURI="http://bio-key.com/20200630/role/statement-note-3-revenue-from-contracts-with-customers">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 008 - Disclosure - Note 3 - Revenue From Contracts With Customers </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-4-pistolstar-inc-acquisition-" roleURI="http://bio-key.com/20200630/role/statement-note-4-pistolstar-inc-acquisition-">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 009 - Disclosure - Note 4 - PistolStar Inc. Acquisition </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-5-accounts-receivable" roleURI="http://bio-key.com/20200630/role/statement-note-5-accounts-receivable">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 010 - Disclosure - Note 5 - Accounts Receivable </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-6-share-based-compensation" roleURI="http://bio-key.com/20200630/role/statement-note-6-share-based-compensation">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 011 - Disclosure - Note 6 - Share Based Compensation </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-7-factoring" roleURI="http://bio-key.com/20200630/role/statement-note-7-factoring">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 012 - Disclosure - Note 7 - Factoring </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-8-inventory-" roleURI="http://bio-key.com/20200630/role/statement-note-8-inventory-">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 013 - Disclosure - Note 8 - Inventory </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-9-resalable-software-license-rights" roleURI="http://bio-key.com/20200630/role/statement-note-9-resalable-software-license-rights">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 014 - Disclosure - Note 9 - Resalable Software License Rights </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-10-investment" roleURI="http://bio-key.com/20200630/role/statement-note-10-investment">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 015 - Disclosure - Note 10 - Investment </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-11-related-party-transactions" roleURI="http://bio-key.com/20200630/role/statement-note-11-related-party-transactions">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 016 - Disclosure - Note 11 - Related Party Transactions </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-12-convertible-notes-payable" roleURI="http://bio-key.com/20200630/role/statement-note-12-convertible-notes-payable">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 017 - Disclosure - Note 12 - Convertible Notes Payable </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-13-leases" roleURI="http://bio-key.com/20200630/role/statement-note-13-leases">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 018 - Disclosure - Note 13 - Leases </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-14-earnings-loss-per-share-common-stock-eps" roleURI="http://bio-key.com/20200630/role/statement-note-14-earnings-loss-per-share-common-stock-eps">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 019 - Disclosure - Note 14 - Earnings (Loss) Per Share - Common Stock ("EPS") </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-15-stockholders-equity" roleURI="http://bio-key.com/20200630/role/statement-note-15-stockholders-equity">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 020 - Disclosure - Note 15 - Stockholders' Equity </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-16-fair-values-of-financial-instruments" roleURI="http://bio-key.com/20200630/role/statement-note-16-fair-values-of-financial-instruments">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 021 - Disclosure - Note 16 - Fair Values of Financial Instruments </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-17-major-customers-and-accounts-receivables" roleURI="http://bio-key.com/20200630/role/statement-note-17-major-customers-and-accounts-receivables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 022 - Disclosure - Note 17 - Major Customers and Accounts Receivables </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-18-payment-protection-program-term-note" roleURI="http://bio-key.com/20200630/role/statement-note-18-payment-protection-program-term-note">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 023 - Disclosure - Note 18 - Payment Protection Program Term Note </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-19-subsequent-events" roleURI="http://bio-key.com/20200630/role/statement-note-19-subsequent-events">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 024 - Disclosure - Note 19 - Subsequent Events </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-significant-accounting-policies-policies" roleURI="http://bio-key.com/20200630/role/statement-significant-accounting-policies-policies">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 025 - Disclosure - Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-3-revenue-from-contracts-with-customers-tables" roleURI="http://bio-key.com/20200630/role/statement-note-3-revenue-from-contracts-with-customers-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 026 - Disclosure - Note 3 - Revenue From Contracts With Customers (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-4-pistolstar-inc-acquisition-tables" roleURI="http://bio-key.com/20200630/role/statement-note-4-pistolstar-inc-acquisition-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 027 - Disclosure - Note 4 - PistolStar Inc. Acquisition (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-5-accounts-receivable-tables" roleURI="http://bio-key.com/20200630/role/statement-note-5-accounts-receivable-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 028 - Disclosure - Note 5 - Accounts Receivable (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-6-share-based-compensation-tables" roleURI="http://bio-key.com/20200630/role/statement-note-6-share-based-compensation-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 029 - Disclosure - Note 6 - Share Based Compensation (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-7-factoring-tables" roleURI="http://bio-key.com/20200630/role/statement-note-7-factoring-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 030 - Disclosure - Note 7 - Factoring (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-8-inventory-tables" roleURI="http://bio-key.com/20200630/role/statement-note-8-inventory-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 031 - Disclosure - Note 8 - Inventory (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-12-convertible-notes-payable-tables" roleURI="http://bio-key.com/20200630/role/statement-note-12-convertible-notes-payable-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 032 - Disclosure - Note 12 - Convertible Notes Payable (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-13-leases-tables" roleURI="http://bio-key.com/20200630/role/statement-note-13-leases-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 033 - Disclosure - Note 13 - Leases (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-14-earnings-loss-per-share-common-stock-eps-tables" roleURI="http://bio-key.com/20200630/role/statement-note-14-earnings-loss-per-share-common-stock-eps-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 034 - Disclosure - Note 14 - Earnings (Loss) Per Share - Common Stock ("EPS") (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-2-going-concern-details-textual" roleURI="http://bio-key.com/20200630/role/statement-note-2-going-concern-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 035 - Disclosure - Note 2 - Going Concern (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-3-revenue-from-contracts-with-customers-details-textual" roleURI="http://bio-key.com/20200630/role/statement-note-3-revenue-from-contracts-with-customers-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 036 - Disclosure - Note 3 - Revenue From Contracts With Customers (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-3-revenue-from-contracts-with-customers-disaggregation-of-revenue-details" roleURI="http://bio-key.com/20200630/role/statement-note-3-revenue-from-contracts-with-customers-disaggregation-of-revenue-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 037 - Disclosure - Note 3 - Revenue From Contracts With Customers - Disaggregation of Revenue (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-4-pistolstar-inc-acquisition-details-textual" roleURI="http://bio-key.com/20200630/role/statement-note-4-pistolstar-inc-acquisition-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 038 - Disclosure - Note 4 - PistolStar Inc. Acquisition (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-4-pistolstar-inc-acquisition-assets-acquired-and-liabilities-assumed-details" roleURI="http://bio-key.com/20200630/role/statement-note-4-pistolstar-inc-acquisition-assets-acquired-and-liabilities-assumed-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 039 - Disclosure - Note 4 - PistolStar Inc. Acquisition - Assets Acquired and Liabilities Assumed (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-4-pistolstar-inc-acquisition-assets-acquired-and-liabilities-assumed-details-parentheticals" roleURI="http://bio-key.com/20200630/role/statement-note-4-pistolstar-inc-acquisition-assets-acquired-and-liabilities-assumed-details-parentheticals">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 040 - Disclosure - Note 4 - PistolStar Inc. Acquisition - Assets Acquired and Liabilities Assumed (Details) (Parentheticals) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-4-pistolstar-inc-acquisition-finitelived-intangible-assets-acquired-details" roleURI="http://bio-key.com/20200630/role/statement-note-4-pistolstar-inc-acquisition-finitelived-intangible-assets-acquired-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 041 - Disclosure - Note 4 - PistolStar Inc. Acquisition - Finite-lived Intangible Assets Acquired (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-4-pistolstar-inc-acquisition-pro-forma-information-details" roleURI="http://bio-key.com/20200630/role/statement-note-4-pistolstar-inc-acquisition-pro-forma-information-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 042 - Disclosure - Note 4 - PistolStar Inc. Acquisition - Pro Forma Information (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-5-accounts-receivable-details-textual" roleURI="http://bio-key.com/20200630/role/statement-note-5-accounts-receivable-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 043 - Disclosure - Note 5 - Accounts Receivable (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-5-accounts-receivable-summary-of-accounts-receivable-details" roleURI="http://bio-key.com/20200630/role/statement-note-5-accounts-receivable-summary-of-accounts-receivable-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 044 - Disclosure - Note 5 - Accounts Receivable - Summary of Accounts Receivable (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-6-share-based-compensation-expenses-for-continuing-operations-details" roleURI="http://bio-key.com/20200630/role/statement-note-6-share-based-compensation-expenses-for-continuing-operations-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 045 - Disclosure - Note 6 - Share Based Compensation - Expenses for Continuing Operations (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-7-factoring-details-textual" roleURI="http://bio-key.com/20200630/role/statement-note-7-factoring-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 046 - Disclosure - Note 7 - Factoring (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-7-factoring-due-from-factor-details" roleURI="http://bio-key.com/20200630/role/statement-note-7-factoring-due-from-factor-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 047 - Disclosure - Note 7 - Factoring - Due From Factor (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-7-factoring-fees-details" roleURI="http://bio-key.com/20200630/role/statement-note-7-factoring-fees-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 048 - Disclosure - Note 7 - Factoring - Fees (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-8-inventory-components-of-inventory-details" roleURI="http://bio-key.com/20200630/role/statement-note-8-inventory-components-of-inventory-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 049 - Disclosure - Note 8 - Inventory - Components of Inventory (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-9-resalable-software-license-rights-details-textual" roleURI="http://bio-key.com/20200630/role/statement-note-9-resalable-software-license-rights-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 050 - Disclosure - Note 9 - Resalable Software License Rights (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-10-investment-details-textual" roleURI="http://bio-key.com/20200630/role/statement-note-10-investment-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 051 - Disclosure - Note 10 - Investment (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-11-related-party-transactions-details-textual" roleURI="http://bio-key.com/20200630/role/statement-note-11-related-party-transactions-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 052 - Disclosure - Note 11 - Related Party Transactions (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-12-convertible-notes-payable-details-textual" roleURI="http://bio-key.com/20200630/role/statement-note-12-convertible-notes-payable-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 053 - Disclosure - Note 12 - Convertible Notes Payable (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-12-convertible-notes-payable-convertible-notes-payable-details" roleURI="http://bio-key.com/20200630/role/statement-note-12-convertible-notes-payable-convertible-notes-payable-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 054 - Disclosure - Note 12 - Convertible Notes Payable - Convertible Notes Payable (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-13-leases-operating-lease-balance-sheet-information-details" roleURI="http://bio-key.com/20200630/role/statement-note-13-leases-operating-lease-balance-sheet-information-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 055 - Disclosure - Note 13 - Leases - Operating Lease Balance Sheet Information (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-13-leases-supplemental-cash-flow-information-related-to-leases-details" roleURI="http://bio-key.com/20200630/role/statement-note-13-leases-supplemental-cash-flow-information-related-to-leases-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 056 - Disclosure - Note 13 - Leases - Supplemental Cash Flow Information Related to Leases (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-13-leases-operating-lease-liability-maturity-details" roleURI="http://bio-key.com/20200630/role/statement-note-13-leases-operating-lease-liability-maturity-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 057 - Disclosure - Note 13 - Leases - Operating Lease Liability Maturity (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-14-earnings-loss-per-share-common-stock-eps-reconciliation-of-numerator-of-basic-and-diluted-eps-calculations-details" roleURI="http://bio-key.com/20200630/role/statement-note-14-earnings-loss-per-share-common-stock-eps-reconciliation-of-numerator-of-basic-and-diluted-eps-calculations-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 058 - Disclosure - Note 14 - Earnings (Loss) Per Share - Common Stock ("EPS") - Reconciliation of Numerator of Basic and Diluted EPS Calculations (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-14-earnings-loss-per-share-common-stock-eps-securities-excluded-from-the-diluted-per-share-calculation-details" roleURI="http://bio-key.com/20200630/role/statement-note-14-earnings-loss-per-share-common-stock-eps-securities-excluded-from-the-diluted-per-share-calculation-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 059 - Disclosure - Note 14 - Earnings (Loss) Per Share - Common Stock ("EPS") - Securities Excluded From the Diluted Per Share Calculation (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-15-stockholders-equity-details-textual" roleURI="http://bio-key.com/20200630/role/statement-note-15-stockholders-equity-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 060 - Disclosure - Note 15 - Stockholders' Equity (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-17-major-customers-and-accounts-receivables-details-textual" roleURI="http://bio-key.com/20200630/role/statement-note-17-major-customers-and-accounts-receivables-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 061 - Disclosure - Note 17 - Major Customers and Accounts Receivables (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-18-payment-protection-program-term-note-details-textual" roleURI="http://bio-key.com/20200630/role/statement-note-18-payment-protection-program-term-note-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 062 - Disclosure - Note 18 - Payment Protection Program Term Note (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-19-subsequent-events-details-textual" roleURI="http://bio-key.com/20200630/role/statement-note-19-subsequent-events-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 063 - Disclosure - Note 19 - Subsequent Events (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="bkyi_ANewEmployeeMember" name="ANewEmployeeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_AccruedLiabilitiesOtherMember" name="AccruedLiabilitiesOtherMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_AdjustmentsToAdditionalPaidInCapitalLegalAndCommitmentFees" name="AdjustmentsToAdditionalPaidInCapitalLegalAndCommitmentFees" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_AmendedNoteMember" name="AmendedNoteMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_AmortizationOfBeneficialConversionFeature" name="AmortizationOfBeneficialConversionFeature" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_AmortizationOfSoftwareLicenseRights" name="AmortizationOfSoftwareLicenseRights" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_BeneficialConversionFeature" name="BeneficialConversionFeature" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted" name="BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_BusinessAcquisitionProFormaWeightedAverageNumberOfOrdinarySharesUsedInComputingBasicAndDilutedLossPerShare" name="BusinessAcquisitionProFormaWeightedAverageNumberOfOrdinarySharesUsedInComputingBasicAndDilutedLossPerShare" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_BusinessCombinationAccountsReceivableAcquired" name="BusinessCombinationAccountsReceivableAcquired" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_BusinessCombinationAccruedExpensesAcquired" name="BusinessCombinationAccruedExpensesAcquired" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_BusinessCombinationDeferredRevenueAcquired" name="BusinessCombinationDeferredRevenueAcquired" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_BusinessCombinationEquipmentAcquired" name="BusinessCombinationEquipmentAcquired" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_BusinessCombinationIntangibleAssetsAcquired" name="BusinessCombinationIntangibleAssetsAcquired" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_BusinessCombinationIssuanceOfNotesPayable" name="BusinessCombinationIssuanceOfNotesPayable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_BusinessCombinationPrepaidExpensesAcquired" name="BusinessCombinationPrepaidExpensesAcquired" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element id="bkyi_ClassOfWarrantOrRightIssuedDuringPeriodPricePerShare" name="ClassOfWarrantOrRightIssuedDuringPeriodPricePerShare" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_ClassOfWarrantOrRightPercentageOfPlacementFeeFromGrossProceedsFromIssuanceOfWarrants" name="ClassOfWarrantOrRightPercentageOfPlacementFeeFromGrossProceedsFromIssuanceOfWarrants" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_ClassOfWarrantOrRightRecordedAsDebtDiscount" name="ClassOfWarrantOrRightRecordedAsDebtDiscount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element id="bkyi_CommissionsAndFeesPercentOfGrossProceeds" name="CommissionsAndFeesPercentOfGrossProceeds" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
<xsd:element id="bkyi_CommitmentFeeAdjustmentEquityImpact" name="CommitmentFeeAdjustmentEquityImpact" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_CommonStockOutstandingIncreaseDecrease" name="CommonStockOutstandingIncreaseDecrease" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_CommonWarrantsMember" name="CommonWarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_ConcentrationRiskNumberOfMajorCustomers" name="ConcentrationRiskNumberOfMajorCustomers" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_ConversionOfSeniorSecuredConvertibleNoteToCommonStockMember" name="ConversionOfSeniorSecuredConvertibleNoteToCommonStockMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_ConvertibleNoteDueInJuly132020Member" name="ConvertibleNoteDueInJuly132020Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_CumulativeAmountOfAmortizationExpenseNetOfCredits" name="CumulativeAmountOfAmortizationExpenseNetOfCredits" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_CurrentAccountsReceivableMember" name="CurrentAccountsReceivableMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_CustomerAMember" name="CustomerAMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_CustomerBMember" name="CustomerBMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_CustomerCMember" name="CustomerCMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_DebtDiscountIssuedWithConvertibleNote" name="DebtDiscountIssuedWithConvertibleNote" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_DebtInstrumentCarryingAmountBeforeConversion" name="DebtInstrumentCarryingAmountBeforeConversion" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element id="bkyi_DebtInstrumentConvertibleBeneficialConversionFeaturePerShare" name="DebtInstrumentConvertibleBeneficialConversionFeaturePerShare" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_DebtInstrumentConvertiblePercent" name="DebtInstrumentConvertiblePercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
<xsd:element id="bkyi_DebtInstrumentConvertiblePremiumPaymentPercentage" name="DebtInstrumentConvertiblePremiumPaymentPercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
<xsd:element id="bkyi_DebtInstrumentConvertibleTotalAmountConverted" name="DebtInstrumentConvertibleTotalAmountConverted" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element id="bkyi_DebtInstrumentCovenantSharesToBePaidCommitmentFeeRepaidPriorToMaturity" name="DebtInstrumentCovenantSharesToBePaidCommitmentFeeRepaidPriorToMaturity" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="instant"/>
<xsd:element id="bkyi_DebtInstrumentDeemedDividendExpense" name="DebtInstrumentDeemedDividendExpense" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_DebtInstrumentNumberOfInstallments" name="DebtInstrumentNumberOfInstallments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
<xsd:element id="bkyi_DebtInstrumentPeriodicPaymentPrincipalDueIn180Days" name="DebtInstrumentPeriodicPaymentPrincipalDueIn180Days" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_DebtInstrumentPeriodicPaymentPrincipalDueIn270Days" name="DebtInstrumentPeriodicPaymentPrincipalDueIn270Days" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_DebtInstrumentUnamortizedDiscountAndBeneficialConversionFeature" name="DebtInstrumentUnamortizedDiscountAndBeneficialConversionFeature" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element id="bkyi_DeemedDividendRelatedToDownRoundFeatures" name="DeemedDividendRelatedToDownRoundFeatures" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_ExercisePriceGreaterThanAverageMarketPriceOfCommonSharesMember" name="ExercisePriceGreaterThanAverageMarketPriceOfCommonSharesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_ExercisePriceLessThanAverageMarketPriceOfCommonSharesMember" name="ExercisePriceLessThanAverageMarketPriceOfCommonSharesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_FactoredAccountsReceivableFactoredAmount" name="FactoredAccountsReceivableFactoredAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="bkyi_FactoredAccountsReceivableMember" name="FactoredAccountsReceivableMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_FactoredAccountsReceivableOriginalInvoiceValue" name="FactoredAccountsReceivableOriginalInvoiceValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element id="bkyi_FactoringArrangementMinimumAmountOfAccountsReceivablePerQuarter" name="FactoringArrangementMinimumAmountOfAccountsReceivablePerQuarter" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_FactoringFees" name="FactoringFees" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_FactoringFeesPercent" name="FactoringFeesPercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
<xsd:element id="bkyi_FactoringFeesTableTextBlock" name="FactoringFeesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_FactoringTextBlock" name="FactoringTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_February2020NoteMember" name="February2020NoteMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_GovernmentGrantIncome" name="GovernmentGrantIncome" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_HardwareMember" name="HardwareMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_IncreaseDecreaseInCapitalizedContractCosts" name="IncreaseDecreaseInCapitalizedContractCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_IncreaseDecreaseInOperatingLeaseLiability" name="IncreaseDecreaseInOperatingLeaseLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_IncreaseDecreaseInSoftwareLicenseRights" name="IncreaseDecreaseInSoftwareLicenseRights" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_InvestmentInHeldToMaturityDebtSecuritiesTerm" name="InvestmentInHeldToMaturityDebtSecuritiesTerm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_InvestmentInHeldtomaturityDebtSecuritiesInterestRate" name="InvestmentInHeldtomaturityDebtSecuritiesInterestRate" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="bkyi_InvestorWarrantMember" name="InvestorWarrantMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_January2020NoteMember" name="January2020NoteMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_June2020NoteMember" name="June2020NoteMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_LegalAndCommitmentFeesRelatedToDebtAndEquityIncludedInAccountsPayable" name="LegalAndCommitmentFeesRelatedToDebtAndEquityIncludedInAccountsPayable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_LesseeOperatingLeaseCostsAssetsAndLiabilitiesTableTextBlock" name="LesseeOperatingLeaseCostsAssetsAndLiabilitiesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_LesseeOperatingLeaseSupplementalCashFlowInformationTableTextBlock" name="LesseeOperatingLeaseSupplementalCashFlowInformationTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_LimitOfBond" name="LimitOfBond" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="bkyi_LindGlobalMacroFundLPMember" name="LindGlobalMacroFundLPMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_May2020NoteMember" name="May2020NoteMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_MonthlyCashRequirementToConductOperationsAndPayDividendObligations" name="MonthlyCashRequirementToConductOperationsAndPayDividendObligations" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_MrMichaelDepasqualeMember" name="MrMichaelDepasqualeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_MrWongKwokFongMember" name="MrWongKwokFongMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_NoteToFinancialStatementDetailsTextual" name="NoteToFinancialStatementDetailsTextual" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_NotesToFinancialStatements" name="NotesToFinancialStatements" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_NotesToFinancialStatementsAbstract" name="NotesToFinancialStatementsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_OperatingLeaseLiabilityAssumedUnderAsc842" name="OperatingLeaseLiabilityAssumedUnderAsc842" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_OverAllotmentWarrantsMember" name="OverAllotmentWarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_PaycheckProtectionProgramCaresActMember" name="PaycheckProtectionProgramCaresActMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_PaymentsOfStockIssuanceCostsBankerFees" name="PaymentsOfStockIssuanceCostsBankerFees" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_PaymentsOfStockIssuanceCostsCommitmentFees" name="PaymentsOfStockIssuanceCostsCommitmentFees" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_PaymentsOfStockIssuanceCostsLegalFees" name="PaymentsOfStockIssuanceCostsLegalFees" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_PercentageOfAccountsReceivableRemittedByFactor" name="PercentageOfAccountsReceivableRemittedByFactor" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
<xsd:element id="bkyi_PercentageOfRemainingBalanceOwnedReserved" name="PercentageOfRemainingBalanceOwnedReserved" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_PercentageOfSupportAndMaintenanceRevenueToLicenseCost" name="PercentageOfSupportAndMaintenanceRevenueToLicenseCost" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_PistolstarMember" name="PistolstarMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_PlacementFeePercentOfAggregateGrossProceeds" name="PlacementFeePercentOfAggregateGrossProceeds" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_PrefundedWarrantsMember" name="PrefundedWarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_PrivateInvestorSPAMember" name="PrivateInvestorSPAMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_PromissoryNoteMember" name="PromissoryNoteMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_ReferralFeeWarrantsMember" name="ReferralFeeWarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_RelatedPartyAgreementTerm" name="RelatedPartyAgreementTerm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_RelatedPartyAgreementTermAutomaticExtension" name="RelatedPartyAgreementTermAutomaticExtension" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_RelatedPartyTransactionMaximumRevenueToTriggerPaymentOfSalesIncentiveFee" name="RelatedPartyTransactionMaximumRevenueToTriggerPaymentOfSalesIncentiveFee" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element id="bkyi_RelatedPartyTransactionMaximumRevenueWarrantsIssuable" name="RelatedPartyTransactionMaximumRevenueWarrantsIssuable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element id="bkyi_RelatedPartyTransactionRevenueToTriggerPaymentOfSalesIncentiveFeePercentOfNetIncome" name="RelatedPartyTransactionRevenueToTriggerPaymentOfSalesIncentiveFeePercentOfNetIncome" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_RelatedPartyTransactionSalesIncentiveFeeForEach5MillionRevenue" name="RelatedPartyTransactionSalesIncentiveFeeForEach5MillionRevenue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_RightofuseAssetAdditionUnderAsc842" name="RightofuseAssetAdditionUnderAsc842" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_SalesIncentiveAgreementWithTTIMember" name="SalesIncentiveAgreementWithTTIMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_SecuredRedeemableConvertibleNoteMember" name="SecuredRedeemableConvertibleNoteMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_SeniorSecuredConvertibleNoteMember" name="SeniorSecuredConvertibleNoteMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_September2015WarrantsMember" name="September2015WarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_SeriesA1ConvertiblePreferredStockMember" name="SeriesA1ConvertiblePreferredStockMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_SeriesB1ConvertiblePreferredStockMember" name="SeriesB1ConvertiblePreferredStockMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_ShareBasedCompensationExcludingDirectorsFees" name="ShareBasedCompensationExcludingDirectorsFees" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_SharebasedCommitmentFees" name="SharebasedCommitmentFees" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_SoftwareLicenseRights" name="SoftwareLicenseRights" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="bkyi_SoftwareLicenseRightsMember" name="SoftwareLicenseRightsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_SoftwareLicenseRightsNoncurrent" name="SoftwareLicenseRightsNoncurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element id="bkyi_StockBasedFeesToDirectorsAndConsultants" name="StockBasedFeesToDirectorsAndConsultants" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_StockIssuableForSalesIncentiveAgreement" name="StockIssuableForSalesIncentiveAgreement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_StockIssuableForSalesIncentiveFeePerEach5MillionRevenue" name="StockIssuableForSalesIncentiveFeePerEach5MillionRevenue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_StockIssuedDuringPeriodSharesCommitmentFees" name="StockIssuedDuringPeriodSharesCommitmentFees" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_StockIssuedDuringPeriodSharesConversionOfWarrant" name="StockIssuedDuringPeriodSharesConversionOfWarrant" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee" name="StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_StockIssuedDuringPeriodValueConversionOfWarrant" name="StockIssuedDuringPeriodValueConversionOfWarrant" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_StockIssuedDuringPeriodValueIssuedForDueDiligenceFee" name="StockIssuedDuringPeriodValueIssuedForDueDiligenceFee" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="bkyi_StockReturnedDuringThePeriodSharesCommitmentFee" name="StockReturnedDuringThePeriodSharesCommitmentFee" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_TechnologyTransferInstituteMember" name="TechnologyTransferInstituteMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_TermOfWarrant" name="TermOfWarrant" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_The2015SoftwareLicenseMember" name="The2015SoftwareLicenseMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_TheAmendedAndOriginalNotesMember" name="TheAmendedAndOriginalNotesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_TheNoteMember" name="TheNoteMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_WarrantsIssuableForEach1MillionRevenueInExcessOf20MilllionMember" name="WarrantsIssuableForEach1MillionRevenueInExcessOf20MilllionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_WarrantsIssuableForSalesIncentiveAgreementMember" name="WarrantsIssuableForSalesIncentiveAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_WarrantsIssuedForConsultingFeesMember" name="WarrantsIssuedForConsultingFeesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_WarrantsIssuedInConnectionWithConvertibleNotesMember" name="WarrantsIssuedInConnectionWithConvertibleNotesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="bkyi_WarrantsIssuedWithConvertibleNotes" name="WarrantsIssuedWithConvertibleNotes" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_WarrantsMember" name="WarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-12-convertible-notes-payable-convertible-notes-payable-details" name="statement-statement-note-12-convertible-notes-payable-convertible-notes-payable-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-12-convertible-notes-payable-tables" name="statement-statement-note-12-convertible-notes-payable-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-13-leases-operating-lease-balance-sheet-information-details" name="statement-statement-note-13-leases-operating-lease-balance-sheet-information-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-13-leases-operating-lease-liability-maturity-details" name="statement-statement-note-13-leases-operating-lease-liability-maturity-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-13-leases-supplemental-cash-flow-information-related-to-leases-details" name="statement-statement-note-13-leases-supplemental-cash-flow-information-related-to-leases-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-13-leases-tables" name="statement-statement-note-13-leases-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-14-earnings-loss-per-share-common-stock-eps-reconciliation-of-numerator-of-basic-and-diluted-eps-calculations-details" name="statement-statement-note-14-earnings-loss-per-share-common-stock-eps-reconciliation-of-numerator-of-basic-and-diluted-eps-calculations-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-14-earnings-loss-per-share-common-stock-eps-securities-excluded-from-the-diluted-per-share-calculation-details" name="statement-statement-note-14-earnings-loss-per-share-common-stock-eps-securities-excluded-from-the-diluted-per-share-calculation-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-14-earnings-loss-per-share-common-stock-eps-tables" name="statement-statement-note-14-earnings-loss-per-share-common-stock-eps-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-3-revenue-from-contracts-with-customers-disaggregation-of-revenue-details" name="statement-statement-note-3-revenue-from-contracts-with-customers-disaggregation-of-revenue-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-3-revenue-from-contracts-with-customers-tables" name="statement-statement-note-3-revenue-from-contracts-with-customers-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-4-pistolstar-inc-acquisition-assets-acquired-and-liabilities-assumed-details" name="statement-statement-note-4-pistolstar-inc-acquisition-assets-acquired-and-liabilities-assumed-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-4-pistolstar-inc-acquisition-assets-acquired-and-liabilities-assumed-details-parentheticals" name="statement-statement-note-4-pistolstar-inc-acquisition-assets-acquired-and-liabilities-assumed-details-parentheticals" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-4-pistolstar-inc-acquisition-finitelived-intangible-assets-acquired-details" name="statement-statement-note-4-pistolstar-inc-acquisition-finitelived-intangible-assets-acquired-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-4-pistolstar-inc-acquisition-pro-forma-information-details" name="statement-statement-note-4-pistolstar-inc-acquisition-pro-forma-information-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-4-pistolstar-inc-acquisition-tables" name="statement-statement-note-4-pistolstar-inc-acquisition-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-5-accounts-receivable-summary-of-accounts-receivable-details" name="statement-statement-note-5-accounts-receivable-summary-of-accounts-receivable-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-5-accounts-receivable-tables" name="statement-statement-note-5-accounts-receivable-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-6-share-based-compensation-expenses-for-continuing-operations-details" name="statement-statement-note-6-share-based-compensation-expenses-for-continuing-operations-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-6-share-based-compensation-tables" name="statement-statement-note-6-share-based-compensation-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-7-factoring-due-from-factor-details" name="statement-statement-note-7-factoring-due-from-factor-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-7-factoring-fees-details" name="statement-statement-note-7-factoring-fees-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-7-factoring-tables" name="statement-statement-note-7-factoring-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-8-inventory-components-of-inventory-details" name="statement-statement-note-8-inventory-components-of-inventory-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-note-8-inventory-tables" name="statement-statement-note-8-inventory-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bkyi_statement-statement-significant-accounting-policies-policies" name="statement-statement-significant-accounting-policies-policies" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>

3 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/07/20  Bio Key International Inc.        8-K:1,2,9   6/30/20    3:371K                                   RDG Filings/FA
 7/01/20  Bio Key International Inc.        8-K:1,2,3,9 6/29/20    5:566K                                   RDG Filings/FA
 6/08/20  Bio Key International Inc.        10-Q        3/31/20   78:5.4M                                   RDG Filings/FA
↑Top
Filing Submission 0001437749-20-018059   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Thu., May 16, 8:59:13.1am ET